Literature DB >> 16741881

Knowledge of partners' genital herpes protects against herpes simplex virus type 2 acquisition.

Anna Wald1, Elizabeth Krantz, Stacy Selke, Ellen Lairson, Rhoda Ashley Morrow, Judy Zeh.   

Abstract

BACKGROUND: Prospective studies of herpes simplex virus type 2 (HSV-2) infection in discordant couples have shown a low rate of transmission. However, unlike partners with genital herpes in prospectively monitored couples, most persons who transmit genital herpes are not aware of having the infection.
METHODS: Because HSV has a short incubation period and most persons who acquire genital herpes can identify the transmitting partner, a time-to-event design was used to assess risks of HSV acquisition among patients with newly acquired genital herpes.
RESULTS: Among 199 persons with laboratory-documented newly acquired genital herpes, the median duration of the sexual relationship with the transmitting partner was 3.5 months, and the median number of sex acts before transmission was 40. The median time to HSV-2 acquisition was greater among participants whose partners disclosed that they had genital herpes, compared with participants whose partners did not disclose their status (270 vs. 60 days; P = .03). In multivariate models, having a partner who disclosed that he or she had genital herpes remained a strong protective factor against genital HSV-2 acquisition (hazard ratio, 0.48 [95% confidence interval, 0.25-0.91]).
CONCLUSION: These findings suggest that testing persons with HSV type-specific serologic assays and encouraging disclosure may result in a decreased risk of HSV-2 transmission to sex partners.

Entities:  

Mesh:

Year:  2006        PMID: 16741881     DOI: 10.1086/504717

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  40 in total

1.  Herpes diagnostic tests and their use.

Authors:  Nicholas J Van Wagoner; Edward W Hook
Journal:  Curr Infect Dis Rep       Date:  2012-04       Impact factor: 3.725

2.  Performance of focus ELISA tests for HSV-1 and HSV-2 antibodies among university students with no history of genital herpes.

Authors:  Hayley D Mark; Joy P Nanda; Jessica Roberts; Anne Rompalo; Johan H Melendez; Jonathan Zenilman
Journal:  Sex Transm Dis       Date:  2007-09       Impact factor: 2.830

3.  Herpes simplex virus type-specific serology: Where does it fit in the diagnostic armamentarium?

Authors:  Todd F Hatchette
Journal:  Can J Infect Dis Med Microbiol       Date:  2007-07       Impact factor: 2.471

Review 4.  HSV-2 serology can be predictive of HIV epidemic potential and hidden sexual risk behavior in the Middle East and North Africa.

Authors:  Laith J Abu-Raddad; Joshua T Schiffer; Rhoda Ashley; Ghina Mumtaz; Ramzi A Alsallaq; Francisca Ayodeji Akala; Iris Semini; Gabriele Riedner; David Wilson
Journal:  Epidemics       Date:  2010-09-15       Impact factor: 4.396

5.  Herpes simplex virus genital infections: current concepts.

Authors:  Carolyn Gardella
Journal:  Curr Infect Dis Rep       Date:  2011-12       Impact factor: 3.725

6.  The impact of brief messages on HSV-2 screening uptake among female defendants in a court setting: a randomized controlled trial utilizing prospect theory.

Authors:  Alexis M Roth; Barbara Van Der Pol; J Dennis Fortenberry; Brian Dodge; Michael Reece; David Certo; Gregory D Zimet
Journal:  J Health Commun       Date:  2014-12-12

7.  Correlates to seroprevalent herpes simplex virus type 2 among rural Appalachian drug users.

Authors:  Dustin B Stephens; April M Young; Ursula L Mullins; Jennifer R Havens
Journal:  J Med Virol       Date:  2015-08-27       Impact factor: 2.327

8.  Serologic screening for herpes simplex virus among university students: a pilot study.

Authors:  Hayley Mark; Joy P Nanda; Alain Joffe; Jessica Roberts; Anne Rompalo; Johan Melendez; Jonathan Zenilman
Journal:  J Am Coll Health       Date:  2008 Nov-Dec

9.  Herpes simplex virus type 2 infection among commercial sex workers in Kunming, Yunnan Province, China.

Authors:  T D Ngo; O Laeyendecker; C Li; H Tai; M Cui; S Lai; T C Quinn
Journal:  Int J STD AIDS       Date:  2008-10       Impact factor: 1.359

10.  Suppressive valacyclovir therapy to reduce genital herpes transmission: good public health policy?

Authors:  Paul E Bonnar
Journal:  Mcgill J Med       Date:  2009-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.